POST-ACUTE SEQUELAE OF COVID-19: CHARACTERIZATION, COMORBIDITIES, AND BIOMARKERS IN A DIVERSE COHORT

Emily Struttmann, Anish Shah, Matthew Moreida, et. al. doi: https://doi.org/10.1101/2024.06.20.24308901 Abstract Introduction Post-acute sequelae of COVID-19 (PASC) is causing a silent pandemic in the U.S. Gulf South, a part of flyover U.S. where patients are quietly withdrawing…[...]

Read More

Asymptomatic COVID-19 Infection-Induced Rhabdomyolysis in the Backdrop of Statin-Cyclosporine Drug Interaction

Vivek Nayak M • FNU Bipasha • Kotresha Neelakantappa, DOI: 10.7759/cureus.68127  Abstract Rhabdomyolysis involves skeletal muscle breakdown leading to high serum creatine kinase (CK) levels and myoglobinuria. Here, we report the case of a middle-aged…[...]

Read More

Increased frequency and mortality in persons with neurological disorders during COVID-19 

Candace M Marsters, Jeffrey A Bakal, Grace Y Lam, Finlay A McAlister, Christopher Power, Brain, awae117, https://doi.org/10.1093/brain/awae117, 20 April 2024 Abstract Determining the frequency and outcomes of neurological disorders associated with coronavirus disease 2019 (COVID-19)…[...]

Read More

Four Other States to Launch Massive Lawsuits Against Pfizer, Accusing the Pharma Giant of Deceiving the Public About COVID Vaccine Safety and Efficacy

By Jim Hᴏft Jun. 24, 2024 Gateway Pundit Four additional states will follow Kansas’s lead by filing large-scale lawsuits against pharmaceutical giant Pfizer. These states allege that the company misled the public…[...]

Read More